Patents Represented by Attorney GlaxoSmithKline
  • Patent number: 7858098
    Abstract: This invention pertains to methods for treating infections caused by human papillomaviruses. It has been determined that immunization with HPV16 and HPV 18 virus like particles provides cross-protection against other HPV types.
    Type: Grant
    Filed: December 16, 2005
    Date of Patent: December 28, 2010
    Assignee: GlaxoSmithKline Biologicals, s.a.
    Inventors: Gary Dubin, Bruce Innis, Moncef Mohammed Slaoui, Martine Anne Cecile Wettendorff